A Case Report of Afebrile Malaria

Madanchi, Nima; Govindu, Rukma; Ammar, Hussam

doi:10.1016/j.amjmed.2019.04.030

Cited by 2 publications

(2 citation statements)

References 2 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Fever may rise to 40 or 41 • C with chills, nausea, and vomiting being common. For patients with immunodeficiency (20) or self-medication with anti-malarial drugs, fever may be atypical or absent. As for COVID-19, with the exception of the 1.6-56.0% of asymptomatic patients (21), 79.43% developed fever, among whom 38.16% were low grade and 44.33% were medium grade (22).…”

Section: Discussionmentioning

confidence: 99%

SARS-CoV-2 and Plasmodium falciparum Co-Infection in a Returning Traveler

Huang

Wang

et al. 2022

Front. Public Health

View full text Add to dashboard Cite

Since December 2019, the Coronavirus Disease 2019 (COVID-19) pandemic has become a non-neglectable context for the whole healthcare system. Under the background of COVID-19, the detection and diagnosis of malaria cases are under challenge. Here, we reported a COVID-19 and malaria co-infection traveler who has a long living history in Cameroon. The case was administered with dihydroartemisinin and piperaquine tablets for malaria, Lopinavir and Ritonavir tablets, Arbidol, recombinant human interferon α-2b and Compound Maxing Yifei mixture for COVID-19, and Zolpidem Tartrate tablets, Diazepam, Paroxetine Hydrochloride tablets, Thymosin α1, and Lianhua Qinwen Jiaonang during the second hospitalization of the patient since the patient has a certain level of anxiety and insomnia with no evidence of inflammatory reactions. After being tested negative two times for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in 48 h, the patient met China's COVID-19 discharge standards and was discharged with stable vital signs and mental state. Since most countries in the sub-Saharan region have a fragile health system, co-infection for both Plasmodium and SARS-CoV-2 may not be uncommon, and raise a challenge in diagnosis, treatment, and prevention for both diseases. We add to the literature on co-infection of P. falciparum malaria and COVID-19 and offer operational advice on diagnosis, prevention, and treatment for the co-infection.

show abstract

Section: Discussionmentioning

confidence: 99%

SARS-CoV-2 and Plasmodium falciparum Co-Infection in a Returning Traveler

Huang

Wang

et al. 2022

Front. Public Health

View full text Add to dashboard Cite

show abstract

“…Cases of malaria infection without fever (afebrile malaria) are very infrequently reported. 5,6 An afebrile malaria case was defined as absence of fever within the past 48 hrs and an axillary temperature 37.5 °C at the time of examination. 7 Our patient had no prior history of fever or fever while being treated in the hospital.…”

mentioning

confidence: 99%

Afebrile Plasmodium Knowlesi Severe Malaria With a Fatal Outcome

Chang¹

2023

J Ayub Med Coll Abbottabad

View full text Add to dashboard Cite

show abstract

A Case Report of Afebrile Malaria

Cited by 2 publications

References 2 publications

SARS-CoV-2 and Plasmodium falciparum Co-Infection in a Returning Traveler

SARS-CoV-2 and Plasmodium falciparum Co-Infection in a Returning Traveler

Afebrile Plasmodium Knowlesi Severe Malaria With a Fatal Outcome

Contact Info

Product

Resources

About